ClinicalTrials.gg
CompletedNCT05201820COPPERUpdated Mar 20, 2024

Cryoanalgesia for Pain Management After Pectus Excavatum Repair

An interventional study of Cryoanalgesia in Pectus Excavatum, sponsored by Istituto Giannina Gaslini. Completed at 1 site in Italy. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2024-03-20.

Sponsored by Istituto Giannina Gaslini · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

Cryoanalgesia for pain management after pectus excavatum repair. COPPER study (CryoanalgesiafOr Pain management after Pectus Excavatum Repair): a randomized controlled trial.

Determine if, in patients more than 12 years of age having cryoanalgesia for pectus excavatum repair analgesia improves the standard of care (epidural analgesia) in term of pain relief and return to normal life 2 weeks after surgery.

Randomized active controlled, parallel group, single-centre, trial (category IIb medical device).

88 patients aged more than 12 years of age scheduled for pectus excavatum repair. After randomization, patients will receive intraoperative cryo-analgesia or standard of care (epidural-analgesia).

PedsQLscale (23 items) two weeks after surgery.

Patients will be followed for 6 months after surgery to determine time until return to normal life and occurrence of any complication related to the use of cryo-analgesia. Numeric Rating Scale (NRS), CALI9, YAPFAQ will be measured at fixed times to determine pain intensity and limitations due to pain. Risk factors for prolonged pain and time needed until achieving discharge criteria from hospital will be reported.

02

Conditions studied

  • Pectus Excavatum

Browse trials for

03

In context

Funnel Chest

79 studies on the registry are indexed under Funnel Chest; 10 are open to participants now.

This study's enrollment of 88 is above the median of 40 across 46 interventional studies indexed under Funnel Chest.

Browse Funnel Chest studies →

Lead sponsor

Istituto Giannina Gaslini is the lead sponsor of 54 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing pectus excavatum repair with NUSS technique
  • aged 12 years or above12
  • signed for cryoanalgesia

Exclusion criteria

Exclusion Criteria:

  • Age of 11 years or below
  • Refuse to receive cryoanalgesia or epidural catheter as primary pain relief
  • Any to cryoanalgesia
  • Difficult follow-up for geographical reasons and/or impossibility by the patient to understand how to perform self-measurements
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
88 participants (actual)

Study arms

  • No intervention
    Standard of care

    Epidural analgesia

  • Experimental
    Cryoanalgesia

    Cryoanalgesia

    Device: Cryoanalgesia

Interventions

  • DeviceCryoanalgesia

    Cryoanalgesia will be applied during surgery on 6 intercostal nerves each side

06

What researchers measure

Primary outcomes

  1. Quality of Life by PedsQL 23 items

    Quality of life after surgery

    Time frame: Two weeks after surgery

Secondary outcomes

  1. YAPFAQ (Youth Acute Pain Functional Ability Questionnaire)

    A scale for assessment of activity limitations in children and adolescents. Range fro 0 to 100

    Time frame: One week after surgery

  2. Pain by VAS

    Numeric pain score 0-10

    Time frame: 1-14 days after surgery

  3. Thoracic hypo-aesthesia

    Cold test assessment (Yes/No)

    Time frame: Six months after surgery

07

Study locations

1 site
  • Istituto Giannina Gaslini
    Genova, Italy
08

References and documents

Publications

  • Arshad SA, Hatton GE, Ferguson DM, Li LT, Austin MT, Tsao K; PAPS SPONSOR. Cryoanalgesia enhances recovery from minimally invasive repair of pectus excavatum resulting in reduced length of stay: A case-matched analysis of NSQIP-Pediatric patients. J Pediatr Surg. 2021 Jul;56(7):1099-1102. doi: 10.1016/j.jpedsurg.2021.03.017. Epub 2021 Mar 24. PubMed 33853733 ↗

Individual participant data

Plan to share: Yes — Once final publication is accepted, other researchers can request IPD

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: At the time of submission for publication

Access criteria: By request

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2022 to primary completion in Mar 2024, 25 months.

Of 31 interventional studies with no phase under Funnel Chest, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 68. This study's 25 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 20, 2021
First posted
Jan 21, 2022
StartActual
Feb 1, 2022
Primary completionActual
Mar 19, 2024
CompletionActual
Mar 19, 2024
Last update
Mar 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05201820
Lead sponsor
Istituto Giannina Gaslini
Responsible party
Nicola Disma, MD (Head of Research and Innovation Unit, Istituto Giannina Gaslini) — Principal investigator
First posted
Jan 21, 2022
Start date
Feb 1, 2022
Primary completion
Mar 19, 2024
Completion
Mar 19, 2024
Last update
Mar 20, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion